Drybench Patent.

Patent and exclusivity dates from July to December 2035 for NDAs, as FDA's Orange Book lists them

Each patent and exclusivity date from July to December 2035 that FDA's Orange Book lists for an NDA, as captured on 14 October 2026. That capture lists a patent or exclusivity for 1,411 NDAs. Each entry is named by its rule and linked to its NDA page. A date here belongs to one patent or one exclusivity on the products named; the same NDA may have other listed dates, earlier or later, so no date here stands for a product.

FDA capture · review pending. Each date is shown as captured from FDA's Orange Book files. Dates are as FDA lists them, and Drybench computes none; patent dates are submitted by the applicant, and FDA does not verify them. Spreadsheet day numbers are shown as dates; a cell that cannot be read as one date is left off this page and shown as written on its NDA page. Where FDA lists a *PED row without flags, its flags are read from the base row and marked so. How this page reads FDA's files has not been independently reviewed by a regulatory-affairs reviewer.

Orange Book captured: 14 October 2026

Listed protection is a range of the dates FDA lists, not a forecast of market entry, and not legal, regulatory or investment advice.

This page covers every NDA whose Orange Book capture lists a patent or exclusivity. It does not cover ANDAs or any BLA. NCE exclusivity dates are here as FDA lists them; NCE-1 dates, computed from them, are on the NCE-1 calendar.

Dates as listed in FDA's Orange Book capture of 14 October 2026. This page does not say whether a date has passed; compare it with today's date and FDA's current Orange Book. This page shows only what the capture of 14 October 2026 lists. It does not show patents or exclusivities listed before and since removed.

NCE-1, one year before a listed NCE exclusivity date and the one date Drybench computes, is on its own page: NCE-1 dates from the Orange Book

Listed dates, 2035 January to June 2035

Listed patent expiry (360)

1 Jul 2035 · NDA 207986 · CIPROFLOXACIN
US 9,220,796, product patent
patent.txt line 7,918
Flags
product
Product numbers
001
4 Jul 2035 · NDA 209305 · HYDROGEN PEROXIDE
US 9,675,639, product and use patent
patent.txt line 10,069
Flags
product use code U-2205
Product numbers
001
6 Jul 2035 · NDA 212801 · OSILODROSTAT PHOSPHATE
US 10,143,680, product patent
patent.txt lines 14,412, 14,418, 14,424
Flags
product
Product numbers
001, 002, 003
9 Jul 2035 · NDA 210428 · METOPROLOL SUCCINATE
US 9,504,655, product patent
patent.txt lines 11,379, 11,381, 11,383, 11,385
Flags
product
Product numbers
001, 002, 003, 004
9 Jul 2035 · NDA 210428 · METOPROLOL SUCCINATE
US 9,700,530, product patent
patent.txt lines 11,380, 11,382, 11,384, 11,386
Flags
product
Product numbers
001, 002, 003, 004
10 Jul 2035 · NDA 204958 · CANGRELOR
US 10,039,780, use patent
patent.txt line 5,182
Flags
use code U-2260
Product numbers
001
10 Jul 2035 · NDA 204958 · CANGRELOR
US 9,295,687, product patent
patent.txt line 5,184
Flags
product
Product numbers
001
10 Jul 2035 · NDA 204958 · CANGRELOR
US 9,439,921, product patent
patent.txt line 5,186
Flags
product
Product numbers
001
10 Jul 2035 · NDA 204958 · CANGRELOR
US 9,700,575, product patent
patent.txt line 5,187
Flags
product
Product numbers
001
10 Jul 2035 · NDA 217424 · BERDAZIMER SODIUM
US 10,322,081, use patent
patent.txt line 19,927
Flags
use code U-3793
Product numbers
001
10 Jul 2035 · NDA 217424 · BERDAZIMER SODIUM
US 10,322,081, use patent
patent.txt line 19,928
Flags
use code U-3794
Product numbers
001
10 Jul 2035 · NDA 217424 · BERDAZIMER SODIUM
US 10,322,081, use patent
patent.txt line 19,929
Flags
use code U-3795
Product numbers
001
10 Jul 2035 · NDA 217424 · BERDAZIMER SODIUM
US 10,322,081, use patent
patent.txt line 19,930
Flags
use code U-3796
Product numbers
001
10 Jul 2035 · NDA 217424 · BERDAZIMER SODIUM
US 10,736,839, use patent
patent.txt line 19,932
Flags
use code U-3790
Product numbers
001
10 Jul 2035 · NDA 217424 · BERDAZIMER SODIUM
US 10,736,839, use patent
patent.txt line 19,933
Flags
use code U-3791
Product numbers
001
10 Jul 2035 · NDA 217424 · BERDAZIMER SODIUM
US 10,736,839, use patent
patent.txt line 19,934
Flags
use code U-3792
Product numbers
001
10 Jul 2035 · NDA 217424 · BERDAZIMER SODIUM
US 11,040,006, product and use patent
patent.txt line 19,935
Flags
product use code U-3789
Product numbers
001
10 Jul 2035 · NDA 217424 · BERDAZIMER SODIUM
US 11,723,858, product and use patent
patent.txt line 19,937
Flags
product use code U-3788
Product numbers
001
13 Jul 2035 · NDA 210852 · CYCLOPHOSPHAMIDE
US 10,849,916, product patent
patent.txt lines 12,176, 12,178, 12,180
Flags
product
Product numbers
001, 002, 003
16 Jul 2035 · NDA 206334 · ORITAVANCIN DIPHOSPHATE
US 9,649,352, product patent
patent.txt line 6,492
Flags
product
Product numbers
001
16 Jul 2035 · NDA 214155 · ORITAVANCIN DIPHOSPHATE
US 9,649,352, substance and product patent
patent.txt line 15,574
Flags
substance product
Product numbers
001
17 Jul 2035 · NDA 215320 · ACETAMINOPHEN; IBUPROFEN SODIUM
US 11,389,416, product patent
patent.txt line 16,774
Flags
product
Product numbers
001
17 Jul 2035 · NDA 215320 · ACETAMINOPHEN; IBUPROFEN SODIUM
US 12,083,087, use patent
patent.txt line 16,779
Flags
use code U-3744
Product numbers
001
17 Jul 2035 · NDA 215320 · ACETAMINOPHEN; IBUPROFEN SODIUM
US 12,083,087, use patent
patent.txt line 16,780
Flags
use code U-3745
Product numbers
001
22 Jul 2035 · NDA 213591 · CAPMATINIB HYDROCHLORIDE
US 10,596,178, product patent
patent.txt lines 15,138, 15,145
Flags
product
Product numbers
001, 002
22 Jul 2035 · NDA 213591 · CAPMATINIB HYDROCHLORIDE
US 12,208,101, product patent
patent.txt lines 15,140, 15,147
Flags
product
Product numbers
001, 002
27 Jul 2035 · NDA 205677 · TASIMELTEON
US 10,376,487, use patent
patent.txt line 5,764
Flags
use code U-2615
Product numbers
001
27 Jul 2035 · NDA 205677 · TASIMELTEON
US 10,376,487, use patent
patent.txt line 5,765
Flags
use code U-3007
Product numbers
001
27 Jul 2035 · NDA 214517 · TASIMELTEON
US 10,376,487, use patent
patent.txt line 15,838
Flags
use code U-3007
Product numbers
001
28 Jul 2035 · NDA 214032 · GALLIUM GA-68 GOZETOTIDE
US 11,027,031, use patent
patent.txt line 15,458
Flags
use code U-3317
Product numbers
001
28 Jul 2035 · NDA 219592 · GALLIUM GA-68 GOZETOTIDE
US 11,027,031, use patent
patent.txt line 21,793
Flags
use code U-3317
Product numbers
001
29 Jul 2035 · NDA 215341 · FINERENONE
US RE49826, substance patent
patent.txt lines 16,794, 16,796, 16,798
Flags
substance
Product numbers
001, 002, 003
4 Aug 2035 · NDA 211580 · INDOCYANINE GREEN
US 10,631,746, product and use patent
patent.txt line 12,885
Flags
product use code U-2815
Product numbers
001
4 Aug 2035 · NDA 211913 · ISOTRETINOIN
US 9,700,535, product patent
patent.txt lines 13,230, 13,232, 13,234, 13,236, 13,238, 13,240
Flags
product
Product numbers
001, 002, 003, 004, 005, 006
7 Aug 2035 · NDA 209863 · TESTOSTERONE ENANTHATE
US 12,629,483, product patent
patent.txt lines 10,931, 10,954, 10,977
Flags
product
Product numbers
001, 002, 003
11 Aug 2035 · NDA 210259 · ACALABRUTINIB
US 11,166,951, use patent
patent.txt line 11,256
Flags
use code U-4426
Product numbers
001
11 Aug 2035 · NDA 210259 · ACALABRUTINIB
US 11,166,951, use patent
patent.txt line 11,257
Flags
use code U-4427
Product numbers
001
11 Aug 2035 · NDA 210259 · ACALABRUTINIB
US 11,166,951, use patent
patent.txt line 11,258
Flags
use code U-4428
Product numbers
001
11 Aug 2035 · NDA 210259 · ACALABRUTINIB
US 11,166,951, use patent
patent.txt line 11,259
Flags
use code U-4429
Product numbers
001
11 Aug 2035 · NDA 210259 · ACALABRUTINIB
US 11,166,951, use patent
patent.txt line 11,260
Flags
use code U-4430
Product numbers
001
11 Aug 2035 · NDA 210259 · ACALABRUTINIB
US 11,166,951, use patent
patent.txt line 11,261
Flags
use code U-4431
Product numbers
001
11 Aug 2035 · NDA 216387 · ACALABRUTINIB MALEATE
US 11,166,951, use patent
patent.txt line 18,783
Flags
use code U-4426
Product numbers
001
11 Aug 2035 · NDA 216387 · ACALABRUTINIB MALEATE
US 11,166,951, use patent
patent.txt line 18,784
Flags
use code U-4427
Product numbers
001
11 Aug 2035 · NDA 216387 · ACALABRUTINIB MALEATE
US 11,166,951, use patent
patent.txt line 18,785
Flags
use code U-4428
Product numbers
001
11 Aug 2035 · NDA 216387 · ACALABRUTINIB MALEATE
US 11,166,951, use patent
patent.txt line 18,786
Flags
use code U-4429
Product numbers
001
11 Aug 2035 · NDA 216387 · ACALABRUTINIB MALEATE
US 11,166,951, use patent
patent.txt line 18,787
Flags
use code U-4430
Product numbers
001
11 Aug 2035 · NDA 216387 · ACALABRUTINIB MALEATE
US 11,166,951, use patent
patent.txt line 18,788
Flags
use code U-4431
Product numbers
001
14 Aug 2035 · NDA 206829 · CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
US 10,125,149, product patent
patent.txt line 6,774
Flags
product
Product numbers
001
14 Aug 2035 · NDA 212306 · SELINEXOR
US 10,519,139, substance and product and use patent
patent.txt lines 13,831, 13,851, 13,870, 13,889, 13,908, 13,927
Flags
substance product use code U-2584
Product numbers
001, 002, 003, 004, 005, 006
14 Aug 2035 · NDA 212306 · SELINEXOR
US 10,519,139, substance and product and use patent
patent.txt lines 13,832, 13,852, 13,871, 13,890, 13,909, 13,928
Flags
substance product use code U-3018
Product numbers
001, 002, 003, 004, 005, 006
14 Aug 2035 · NDA 212306 · SELINEXOR
US 11,746,102, use patent
patent.txt lines 13,837, 13,857, 13,876, 13,895, 13,914, 13,933
Flags
use code U-2584
Product numbers
001, 002, 003, 004, 005, 006
14 Aug 2035 · NDA 212306 · SELINEXOR
US 11,746,102, use patent
patent.txt lines 13,838, 13,858, 13,877, 13,896, 13,915, 13,934
Flags
use code U-3018
Product numbers
001, 002, 003, 004, 005, 006
14 Aug 2035 · NDA 212306 · SELINEXOR
US 11,753,401, product and use patent
patent.txt lines 13,839, 13,859, 13,878, 13,897, 13,916, 13,935
Flags
product use code U-2584
Product numbers
001, 002, 003, 004, 005, 006
14 Aug 2035 · NDA 212306 · SELINEXOR
US 11,753,401, product and use patent
patent.txt lines 13,840, 13,860, 13,879, 13,898, 13,917, 13,936
Flags
product use code U-3018
Product numbers
001, 002, 003, 004, 005, 006
14 Aug 2035 · NDA 212306 · SELINEXOR
US 11,807,629, substance and product patent
patent.txt lines 13,844, 13,863, 13,882, 13,901
Flags
substance product
Product numbers
001, 002, 003, 004
14 Aug 2035 · NDA 212306 · SELINEXOR
US 11,807,629, substance patent
patent.txt lines 13,920, 13,939
Flags
substance
Product numbers
005, 006
14 Aug 2035 · NDA 214103 · LUMASIRAN SODIUM
US 10,612,024, substance and product and use patent
patent.txt line 15,540
Flags
substance product use code U-2995
Product numbers
001
14 Aug 2035 · NDA 214103 · LUMASIRAN SODIUM
US 10,612,027, substance and product and use patent
patent.txt line 15,541
Flags
substance product use code U-2995
Product numbers
001
14 Aug 2035 · NDA 214103 · LUMASIRAN SODIUM
US 11,401,517, substance and product and use patent
patent.txt line 15,544
Flags
substance product use code U-2995
Product numbers
001
14 Aug 2035 · NDA 215515 · VUTRISIRAN SODIUM
US 10,612,024, substance and product and use patent
patent.txt line 17,416
Flags
substance product use code U-3396
Product numbers
001
14 Aug 2035 · NDA 215515 · VUTRISIRAN SODIUM
US 11,401,517, substance and product and use patent
patent.txt line 17,420
Flags
substance product use code U-3396
Product numbers
001
17 Aug 2035 · NDA 209115 · RUCAPARIB CAMSYLATE
US 10,130,636, use patent
patent.txt lines 9,728, 9,747, 9,766
Flags
use code U-2012
Product numbers
001, 002, 003
17 Aug 2035 · NDA 209115 · RUCAPARIB CAMSYLATE
US 10,130,636, use patent
patent.txt lines 9,729, 9,748, 9,767
Flags
use code U-2101
Product numbers
001, 002, 003
17 Aug 2035 · NDA 209115 · RUCAPARIB CAMSYLATE
US 10,130,636, use patent
patent.txt lines 9,730, 9,749, 9,768
Flags
use code U-2273
Product numbers
001, 002, 003
17 Aug 2035 · NDA 209115 · RUCAPARIB CAMSYLATE
US 10,130,636, use patent
patent.txt lines 9,731, 9,750, 9,769
Flags
use code U-2830
Product numbers
001, 002, 003
17 Aug 2035 · NDA 209115 · RUCAPARIB CAMSYLATE
US 9,987,285, product patent
patent.txt lines 9,746, 9,765, 9,784
Flags
product
Product numbers
001, 002, 003
17 Aug 2035 · NDA 209830 · ARIPIPRAZOLE LAUROXIL
US 10,688,091, product patent
patent.txt line 10,888
Flags
product
Product numbers
001
17 Aug 2035 · NDA 209830 · ARIPIPRAZOLE LAUROXIL
US 10,849,894, use patent
patent.txt line 10,889
Flags
use code U-543
Product numbers
001
17 Aug 2035 · NDA 209830 · ARIPIPRAZOLE LAUROXIL
US 11,154,552, product patent
patent.txt line 10,890
Flags
product
Product numbers
001
19 Aug 2035 · NDA 220106 · BREPOCITINIB TOSYLATE
US 11,197,867, substance and product patent
patent.txt line 22,097
Flags
substance product
Product numbers
001
19 Aug 2035 · NDA 220106 · BREPOCITINIB TOSYLATE
US 9,663,526, substance and product patent
patent.txt line 22,098
Flags
substance product
Product numbers
001
20 Aug 2035 · NDA 218230 · GEPOTIDACIN MESYLATE
US 10,702,521, use patent
patent.txt line 20,918
Flags
use code U-4361
Product numbers
001
20 Aug 2035 · NDA 218230 · GEPOTIDACIN MESYLATE
US 11,229,646, use patent
patent.txt line 20,919
Flags
use code U-4361
Product numbers
001
26 Aug 2035 · NDA 206947 · LENVATINIB MESYLATE
US 10,259,791, substance patent
patent.txt lines 6,875, 6,896
Flags
substance
Product numbers
001, 002
26 Aug 2035 · NDA 206947 · LENVATINIB MESYLATE
US 10,407,393, substance patent
patent.txt lines 6,877, 6,898
Flags
substance
Product numbers
001, 002
26 Aug 2035 · NDA 206947 · LENVATINIB MESYLATE
US 11,186,547, substance patent
patent.txt lines 6,881, 6,902
Flags
substance
Product numbers
001, 002
27 Aug 2035 · NDA 210922 · PATISIRAN SODIUM
US 11,079,379, substance and product and use patent
patent.txt line 12,395
Flags
substance product use code U-2378
Product numbers
001
29 Aug 2035 · NDA 205677 · TASIMELTEON
US 10,179,119, use patent
patent.txt line 5,763
Flags
use code U-3003
Product numbers
001
29 Aug 2035 · NDA 205677 · TASIMELTEON
US 11,266,622, use patent
patent.txt line 5,777
Flags
use code U-3003
Product numbers
001
29 Aug 2035 · NDA 214517 · TASIMELTEON
US 10,179,119, use patent
patent.txt line 15,837
Flags
use code U-3003
Product numbers
001
29 Aug 2035 · NDA 214517 · TASIMELTEON
US 11,266,622, use patent
patent.txt line 15,845
Flags
use code U-3003
Product numbers
001
31 Aug 2035 · NDA 205108 · SOTALOL HYDROCHLORIDE
US 9,724,297, product and use patent
patent.txt line 5,214
Flags
product use code U-2096
Product numbers
001
31 Aug 2035 · NDA 212161 · TAFAMIDIS
US 9,770,441, substance and product and use patent
patent.txt line 13,613
Flags
substance product use code U-2524
Product numbers
001
3 Sep 2035 · NDA 209445 · CEFIDEROCOL SULFATE TOSYLATE
US 10,004,750, substance and product patent
patent.txt line 10,380
Flags
substance product
Product numbers
001
3 Sep 2035 · NDA 209445 · CEFIDEROCOL SULFATE TOSYLATE
US 9,949,982, product patent
patent.txt line 10,384
Flags
product
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 10,335,390, product and use patent
patent.txt line 10,222
Flags
product use code U-2583
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 10,335,390, product and use patent
patent.txt line 10,223
Flags
product use code U-3270
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 10,682,338, product and use patent
patent.txt line 10,224
Flags
product use code U-2583
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 10,682,338, product and use patent
patent.txt line 10,225
Flags
product use code U-3270
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 10,849,884, product and use patent
patent.txt line 10,226
Flags
product use code U-2583
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 10,849,884, product and use patent
patent.txt line 10,227
Flags
product use code U-3169
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 10,849,884, product and use patent
patent.txt line 10,228
Flags
product use code U-3270
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 10,849,884, product and use patent
patent.txt line 10,229
Flags
product use code U-3302
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 10,857,133, product and use patent
patent.txt line 10,230
Flags
product use code U-2583
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 10,857,133, product and use patent
patent.txt line 10,231
Flags
product use code U-3270
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,000,507, product and use patent
patent.txt line 10,232
Flags
product use code U-2583
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,000,507, product and use patent
patent.txt line 10,233
Flags
product use code U-3169
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,000,507, product and use patent
patent.txt line 10,234
Flags
product use code U-3270
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,000,507, product and use patent
patent.txt line 10,235
Flags
product use code U-3302
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,000,508, product and use patent
patent.txt line 10,236
Flags
product use code U-2583
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,000,508, product and use patent
patent.txt line 10,237
Flags
product use code U-3169
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,000,508, product and use patent
patent.txt line 10,238
Flags
product use code U-3270
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,000,508, product and use patent
patent.txt line 10,239
Flags
product use code U-3302
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,020,377, product and use patent
patent.txt line 10,240
Flags
product use code U-2583
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,020,377, product and use patent
patent.txt line 10,241
Flags
product use code U-3169
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,020,377, product and use patent
patent.txt line 10,242
Flags
product use code U-3270
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,020,377, product and use patent
patent.txt line 10,243
Flags
product use code U-3302
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,324,721, product and use patent
patent.txt line 10,244
Flags
product use code U-2583
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,324,721, product and use patent
patent.txt line 10,245
Flags
product use code U-3169
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,324,721, product and use patent
patent.txt line 10,246
Flags
product use code U-3270
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,324,721, product and use patent
patent.txt line 10,247
Flags
product use code U-3302
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,602,522, product and use patent
patent.txt line 10,248
Flags
product use code U-3169
Product numbers
001
4 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,602,522, product and use patent
patent.txt line 10,249
Flags
product use code U-3302
Product numbers
001
7 Sep 2035 · NDA 217564 · FRUQUINTINIB
US 10,519,142, substance and product and use patent
patent.txt lines 20,000, 20,004
Flags
substance product use code U-3753
Product numbers
001, 002
7 Sep 2035 · NDA 217564 · FRUQUINTINIB
US 11,046,674, use patent
patent.txt lines 20,001, 20,005
Flags
use code U-3753
Product numbers
001, 002
8 Sep 2035 · NDA 209830 · ARIPIPRAZOLE LAUROXIL
US 10,016,415, product patent
patent.txt line 10,886
Flags
product
Product numbers
001
10 Sep 2035 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 10,869,844, use patent
patent.txt line 12,638
Flags
use code U-3034
Product numbers
001
10 Sep 2035 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 10,869,844, use patent
patent.txt line 12,639
Flags
use code U-3035
Product numbers
001
10 Sep 2035 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 10,869,844, use patent
patent.txt line 12,640
Flags
use code U-3036
Product numbers
001
10 Sep 2035 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 10,869,844, use patent
patent.txt line 12,641
Flags
use code U-4113
Product numbers
001
10 Sep 2035 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 10,869,844, use patent
patent.txt line 12,642
Flags
use code U-4114
Product numbers
001
10 Sep 2035 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 11,173,134, use patent
patent.txt line 12,643
Flags
use code U-3257
Product numbers
001
10 Sep 2035 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 11,173,134, use patent
patent.txt line 12,644
Flags
use code U-3536
Product numbers
001
10 Sep 2035 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 11,173,134, use patent
patent.txt line 12,645
Flags
use code U-4115
Product numbers
001
10 Sep 2035 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 11,311,500, use patent
patent.txt line 12,646
Flags
use code U-3034
Product numbers
001
10 Sep 2035 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 11,311,500, use patent
patent.txt line 12,647
Flags
use code U-3035
Product numbers
001
10 Sep 2035 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 11,311,500, use patent
patent.txt line 12,648
Flags
use code U-3036
Product numbers
001
10 Sep 2035 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 11,311,500, use patent
patent.txt line 12,649
Flags
use code U-4116
Product numbers
001
10 Sep 2035 · NDA 211243 · ESKETAMINE HYDROCHLORIDE
US 11,311,500, use patent
patent.txt line 12,650
Flags
use code U-4117
Product numbers
001
11 Sep 2035 · NDA 209531 · NUSINERSEN SODIUM
US 10,436,802, use patent
patent.txt line 10,605
Flags
use code U-1941
Product numbers
001
11 Sep 2035 · NDA 209531 · NUSINERSEN SODIUM
US 10,436,802, use patent
patent.txt line 10,606
Flags
use code U-1942
Product numbers
001
11 Sep 2035 · NDA 209531 · NUSINERSEN SODIUM
US 10,436,802, use patent
patent.txt line 10,607
Flags
use code U-1943
Product numbers
001
11 Sep 2035 · NDA 209531 · NUSINERSEN SODIUM
US 10,436,802, use patent
patent.txt line 10,608
Flags
use code U-1944
Product numbers
001
11 Sep 2035 · NDA 209531 · NUSINERSEN SODIUM
US 10,436,802, use patent
patent.txt line 10,609
Flags
use code U-2093
Product numbers
001
11 Sep 2035 · NDA 209531 · NUSINERSEN SODIUM
US 10,436,802, use patent
patent.txt line 10,610
Flags
use code U-2094
Product numbers
001
14 Sep 2035 · NDA 208437 · GLYCOPYRROLATE
US 10,376,661, product patent
patent.txt line 8,621
Flags
product
Product numbers
001
15 Sep 2035 · NDA 217389 · ENSIFENTRINE
US 10,945,950, product patent
patent.txt line 19,905
Flags
product
Product numbers
001
15 Sep 2035 · NDA 217389 · ENSIFENTRINE
US 9,956,171, product and use patent
patent.txt line 19,909
Flags
product use code U-3962
Product numbers
001
16 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,684,607, product and use patent
patent.txt line 10,250
Flags
product use code U-2583
Product numbers
001
16 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,684,607, product and use patent
patent.txt line 10,251
Flags
product use code U-3169
Product numbers
001
16 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,684,607, product and use patent
patent.txt line 10,252
Flags
product use code U-3270
Product numbers
001
16 Sep 2035 · NDA 209363 · SECNIDAZOLE
US 11,684,607, product and use patent
patent.txt line 10,253
Flags
product use code U-3302
Product numbers
001
18 Sep 2035 · NDA 209296 · APREPITANT
US 10,500,208, product patent
patent.txt line 10,025
Flags
product
Product numbers
001
18 Sep 2035 · NDA 209296 · APREPITANT
US 10,624,850, use patent
patent.txt line 10,026
Flags
use code U-2161
Product numbers
001
18 Sep 2035 · NDA 209296 · APREPITANT
US 10,953,018, use patent
patent.txt line 10,027
Flags
use code U-2161
Product numbers
001
18 Sep 2035 · NDA 209296 · APREPITANT
US 11,173,118, product patent
patent.txt line 10,028
Flags
product
Product numbers
001
18 Sep 2035 · NDA 209296 · APREPITANT
US 11,744,800, product patent
patent.txt line 10,029
Flags
product
Product numbers
001
18 Sep 2035 · NDA 209296 · APREPITANT
US 12,115,254, product patent
patent.txt line 10,030
Flags
product
Product numbers
001
18 Sep 2035 · NDA 209296 · APREPITANT
US 12,115,255, product patent
patent.txt line 10,031
Flags
product
Product numbers
001
18 Sep 2035 · NDA 209296 · APREPITANT
US 12,290,520, product patent
patent.txt line 10,032
Flags
product
Product numbers
001
18 Sep 2035 · NDA 209296 · APREPITANT
US 9,561,229, product and use patent
patent.txt line 10,033
Flags
product use code U-2161
Product numbers
001
18 Sep 2035 · NDA 209296 · APREPITANT
US 9,808,465, use patent
patent.txt line 10,034
Flags
use code U-2161
Product numbers
001
18 Sep 2035 · NDA 209296 · APREPITANT
US 9,974,742, product patent
patent.txt line 10,035
Flags
product
Product numbers
001
18 Sep 2035 · NDA 209296 · APREPITANT
US 9,974,793, product patent
patent.txt line 10,036
Flags
product
Product numbers
001
18 Sep 2035 · NDA 209296 · APREPITANT
US 9,974,794, product and use patent
patent.txt line 10,037
Flags
product use code U-2161
Product numbers
001
18 Sep 2035 · NDA 215814 · OLUTASIDENIB
US 10,414,752, product patent
patent.txt line 17,521
Flags
product
Product numbers
001
18 Sep 2035 · NDA 215814 · OLUTASIDENIB
US 10,550,098, product patent
patent.txt line 17,523
Flags
product
Product numbers
001
18 Sep 2035 · NDA 215814 · OLUTASIDENIB
US 11,498,913, product patent
patent.txt line 17,529
Flags
product
Product numbers
001
18 Sep 2035 · NDA 215814 · OLUTASIDENIB
US 12,275,715, substance and product and use patent
patent.txt line 17,533
Flags
substance product use code U-3684
Product numbers
001
18 Sep 2035 · NDA 215814 · OLUTASIDENIB
US 9,834,539, substance and product and use patent
patent.txt line 17,534
Flags
substance product use code U-3497
Product numbers
001
18 Sep 2035 · NDA 216457 · APREPITANT
US 10,500,208, product patent
patent.txt line 18,804
Flags
product
Product numbers
001
18 Sep 2035 · NDA 216457 · APREPITANT
US 10,624,850, use patent
patent.txt line 18,805
Flags
use code U-3440
Product numbers
001
18 Sep 2035 · NDA 216457 · APREPITANT
US 10,953,018, use patent
patent.txt line 18,806
Flags
use code U-3440
Product numbers
001
18 Sep 2035 · NDA 216457 · APREPITANT
US 11,173,118, product patent
patent.txt line 18,807
Flags
product
Product numbers
001
18 Sep 2035 · NDA 216457 · APREPITANT
US 11,744,800, product and use patent
patent.txt line 18,808
Flags
product use code U-3690
Product numbers
001
18 Sep 2035 · NDA 216457 · APREPITANT
US 11,878,074, use patent
patent.txt line 18,809
Flags
use code U-3787
Product numbers
001
18 Sep 2035 · NDA 216457 · APREPITANT
US 12,115,254, product patent
patent.txt line 18,810
Flags
product
Product numbers
001
18 Sep 2035 · NDA 216457 · APREPITANT
US 12,115,255, product patent
patent.txt line 18,811
Flags
product
Product numbers
001
18 Sep 2035 · NDA 216457 · APREPITANT
US 12,290,520, product patent
patent.txt line 18,812
Flags
product
Product numbers
001
18 Sep 2035 · NDA 216457 · APREPITANT
US 9,561,229, product and use patent
patent.txt line 18,813
Flags
product use code U-3440
Product numbers
001
18 Sep 2035 · NDA 216457 · APREPITANT
US 9,808,465, use patent
patent.txt line 18,814
Flags
use code U-3440
Product numbers
001
18 Sep 2035 · NDA 216457 · APREPITANT
US 9,974,742, product patent
patent.txt line 18,815
Flags
product
Product numbers
001
18 Sep 2035 · NDA 216457 · APREPITANT
US 9,974,793, product patent
patent.txt line 18,816
Flags
product
Product numbers
001
18 Sep 2035 · NDA 216457 · APREPITANT
US 9,974,794, product and use patent
patent.txt line 18,817
Flags
product use code U-3440
Product numbers
001
25 Sep 2035 · NDA 205718 · NETUPITANT; PALONOSETRON HYDROCHLORIDE
US 10,233,154, substance patent
patent.txt line 5,812
Flags
substance
Product numbers
001
25 Sep 2035 · NDA 205718 · NETUPITANT; PALONOSETRON HYDROCHLORIDE
US 10,676,440, substance and product patent
patent.txt line 5,813
Flags
substance product
Product numbers
001
25 Sep 2035 · NDA 205718 · NETUPITANT; PALONOSETRON HYDROCHLORIDE
US 10,961,195, substance and product patent
patent.txt line 5,815
Flags
substance product
Product numbers
001
25 Sep 2035 · NDA 205718 · NETUPITANT; PALONOSETRON HYDROCHLORIDE
US 9,951,016, substance and product patent
patent.txt line 5,823
Flags
substance product
Product numbers
001
28 Sep 2035 · NDA 022114 · LIDOCAINE HYDROCHLORIDE
US 9,370,622, use patent
patent.txt line 1,083
Flags
use code U-1870
Product numbers
001
28 Sep 2035 · NDA 215206 · ATOGEPANT
US 8,754,096, substance and product and use patent
patent.txt lines 16,564, 16,571, 16,577
Flags
substance product use code U-3534
Product numbers
001, 002, 003
30 Sep 2035 · NDA 215211 · MIGLUSTAT
US 10,208,299, substance and product and use patent
patent.txt line 16,580
Flags
substance product use code U-3726
Product numbers
001
30 Sep 2035 · NDA 215211 · MIGLUSTAT
US 10,961,522, use patent
patent.txt line 16,583
Flags
use code U-3726
Product numbers
001
30 Sep 2035 · NDA 215211 · MIGLUSTAT
US 11,753,632, use patent
patent.txt line 16,586
Flags
use code U-3726
Product numbers
001
1 Oct 2035 · NDA 216675 · PERFLUOROHEXYLOCTANE
US 10,576,154, use patent
patent.txt line 18,916
Flags
use code U-1900
Product numbers
001
6 Oct 2035 · NDA 212273 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 10,758,534, substance and product and use patent
patent.txt line 13,665
Flags
substance product use code U-3028
Product numbers
001
6 Oct 2035 · NDA 212273 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 10,758,534, substance and product and use patent
patent.txt lines 13,666, 13,739
Flags
substance product use code U-3144
Product numbers
001, 002
6 Oct 2035 · NDA 212273 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 10,758,534, substance and product and use patent
patent.txt lines 13,667, 13,740
Flags
substance product use code U-4073
Product numbers
001, 002
6 Oct 2035 · NDA 212273 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 10,758,534, substance and product and use patent
patent.txt lines 13,668, 13,741
Flags
substance product use code U-4475
Product numbers
001, 002
6 Oct 2035 · NDA 212273 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 11,426,407, substance and product and use patent
patent.txt lines 13,676, 13,748
Flags
substance product use code U-3425
Product numbers
001, 002
6 Oct 2035 · NDA 212273 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 11,426,407, substance and product and use patent
patent.txt lines 13,677, 13,749
Flags
substance product use code U-4070
Product numbers
001, 002
6 Oct 2035 · NDA 212273 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 11,426,407, substance and product and use patent
patent.txt lines 13,678, 13,750
Flags
substance product use code U-4475
Product numbers
001, 002
6 Oct 2035 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 10,758,534, substance and product and use patent
patent.txt lines 20,073, 20,146
Flags
substance product use code U-3589
Product numbers
001, 002
6 Oct 2035 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 10,758,534, substance and product and use patent
patent.txt lines 20,074, 20,147
Flags
substance product use code U-4066
Product numbers
001, 002
6 Oct 2035 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 10,758,534, substance and product and use patent
patent.txt lines 20,075, 20,148
Flags
substance product use code U-4476
Product numbers
001, 002
6 Oct 2035 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 11,426,407, substance and product and use patent
patent.txt lines 20,085, 20,158
Flags
substance product use code U-3595
Product numbers
001, 002
6 Oct 2035 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 11,426,407, substance and product and use patent
patent.txt lines 20,086, 20,159
Flags
substance product use code U-4058
Product numbers
001, 002
6 Oct 2035 · NDA 217660 · ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US 11,426,407, substance and product and use patent
patent.txt lines 20,087, 20,160
Flags
substance product use code U-4476
Product numbers
001, 002
9 Oct 2035 · NDA 214103 · LUMASIRAN SODIUM
US 10,478,500, substance and product and use patent
patent.txt line 15,538
Flags
substance product use code U-2995
Product numbers
001
9 Oct 2035 · NDA 214103 · LUMASIRAN SODIUM
US 11,446,380, substance and product patent
patent.txt line 15,545
Flags
substance product
Product numbers
001
9 Oct 2035 · NDA 215842 · NEDOSIRAN SODIUM
US 10,351,854, substance and product patent
patent.txt lines 17,553, 17,559, 17,565
Flags
substance product
Product numbers
001, 002, 003
9 Oct 2035 · NDA 215842 · NEDOSIRAN SODIUM
US 10,738,311, substance and product and use patent
patent.txt lines 17,554, 17,560, 17,566
Flags
substance product use code U-3709
Product numbers
001, 002, 003
9 Oct 2035 · NDA 215842 · NEDOSIRAN SODIUM
US 11,359,203, substance and product and use patent
patent.txt lines 17,557, 17,563, 17,569
Flags
substance product use code U-3709
Product numbers
001, 002, 003
10 Oct 2035 · NDA 219972 · SEVABERTINIB
US 10,428,063, substance and product patent
patent.txt line 22,077
Flags
substance product
Product numbers
001
12 Oct 2035 · NDA 212801 · OSILODROSTAT PHOSPHATE
US 10,709,691, use patent
patent.txt lines 14,413, 14,419
Flags
use code U-4529
Product numbers
001, 002
12 Oct 2035 · NDA 212801 · OSILODROSTAT PHOSPHATE
US 10,709,691, use patent
patent.txt line 14,425
Flags
use code U-2770
Product numbers
003
13 Oct 2035 · NDA 210365 · CANNABIDIOL
US 10,918,608, use patent
patent.txt line 11,334
Flags
use code U-3071
Product numbers
001
13 Oct 2035 · NDA 210365 · CANNABIDIOL
US 10,918,608, use patent
patent.txt line 11,335
Flags
use code U-3072
Product numbers
001
13 Oct 2035 · NDA 210365 · CANNABIDIOL
US 10,918,608, use patent
patent.txt line 11,336
Flags
use code U-3073
Product numbers
001
13 Oct 2035 · NDA 210365 · CANNABIDIOL
US 11,065,209, use patent
patent.txt line 11,339
Flags
use code U-3071
Product numbers
001
13 Oct 2035 · NDA 210365 · CANNABIDIOL
US 11,096,905, substance and product and use patent
patent.txt line 11,340
Flags
substance product use code U-2780
Product numbers
001
13 Oct 2035 · NDA 210365 · CANNABIDIOL
US 11,096,905, substance and product and use patent
patent.txt line 11,341
Flags
substance product use code U-2781
Product numbers
001
13 Oct 2035 · NDA 210365 · CANNABIDIOL
US 11,400,055, use patent
patent.txt line 11,351
Flags
use code U-3071
Product numbers
001
13 Oct 2035 · NDA 219008 · LAZERTINIB MESYLATE
US 9,593,098, substance and product and use patent
patent.txt lines 21,443, 21,452
Flags
substance product use code U-3985
Product numbers
001, 002
13 Oct 2035 · NDA 219008 · LAZERTINIB MESYLATE
US RE50528, substance and product and use patent
patent.txt lines 21,444, 21,453
Flags
substance product use code U-3985
Product numbers
001, 002
14 Oct 2035 · NDA 207078 · SODIUM ZIRCONIUM CYCLOSILICATE
US 10,300,087, substance and use patent
patent.txt lines 7,009, 7,023
Flags
substance use code U-2312
Product numbers
001, 002
14 Oct 2035 · NDA 207078 · SODIUM ZIRCONIUM CYCLOSILICATE
US 11,738,044, use patent
patent.txt lines 7,015, 7,028
Flags
use code U-2312
Product numbers
001, 002
14 Oct 2035 · NDA 207078 · SODIUM ZIRCONIUM CYCLOSILICATE
US 9,592,253, substance and use patent
patent.txt lines 7,019, 7,032
Flags
substance use code U-2312
Product numbers
001, 002
16 Oct 2035 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 10,369,155, use patent
patent.txt line 13,091
Flags
use code U-2736
Product numbers
001
16 Oct 2035 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 10,369,155, use patent
patent.txt line 13,092
Flags
use code U-2852
Product numbers
001
16 Oct 2035 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 10,369,155, use patent
patent.txt line 13,093
Flags
use code U-2853
Product numbers
001
16 Oct 2035 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,889,138, use patent
patent.txt line 13,129
Flags
use code U-2736
Product numbers
001
16 Oct 2035 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,889,138, use patent
patent.txt line 13,130
Flags
use code U-2852
Product numbers
001
16 Oct 2035 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 9,889,138, use patent
patent.txt line 13,131
Flags
use code U-2853
Product numbers
001
18 Oct 2035 · NDA 209863 · TESTOSTERONE ENANTHATE
US 11,191,908, product patent
patent.txt lines 10,925, 10,948, 10,971
Flags
product
Product numbers
001, 002, 003
18 Oct 2035 · NDA 212018 · ERDAFITINIB
US 12,037,644, use patent
patent.txt lines 13,395, 13,413, 13,431
Flags
use code U-3972
Product numbers
001, 002, 003
19 Oct 2035 · NDA 213978 · VARENICLINE TARTRATE
US 10,456,396, product and use patent
patent.txt line 15,406
Flags
product use code U-1900
Product numbers
001
19 Oct 2035 · NDA 213978 · VARENICLINE TARTRATE
US 11,224,598, use patent
patent.txt line 15,407
Flags
use code U-1900
Product numbers
001
19 Oct 2035 · NDA 213978 · VARENICLINE TARTRATE
US 11,903,941, use patent
patent.txt line 15,408
Flags
use code U-1900
Product numbers
001
19 Oct 2035 · NDA 213978 · VARENICLINE TARTRATE
US 11,903,942, product patent
patent.txt line 15,409
Flags
product
Product numbers
001
19 Oct 2035 · NDA 213978 · VARENICLINE TARTRATE
US 11,903,943, use patent
patent.txt line 15,410
Flags
use code U-1900
Product numbers
001
19 Oct 2035 · NDA 213978 · VARENICLINE TARTRATE
US 11,911,380, use patent
patent.txt line 15,411
Flags
use code U-1900
Product numbers
001
19 Oct 2035 · NDA 213978 · VARENICLINE TARTRATE
US 12,576,080, use patent
patent.txt line 15,412
Flags
use code U-1900
Product numbers
001
19 Oct 2035 · NDA 213978 · VARENICLINE TARTRATE
US 12,653,824, product patent
patent.txt line 15,413
Flags
product
Product numbers
001
19 Oct 2035 · NDA 213978 · VARENICLINE TARTRATE
US 9,504,644, use patent
patent.txt line 15,414
Flags
use code U-1900
Product numbers
001
19 Oct 2035 · NDA 213978 · VARENICLINE TARTRATE
US 9,504,645, product patent
patent.txt line 15,415
Flags
product
Product numbers
001
19 Oct 2035 · NDA 213978 · VARENICLINE TARTRATE
US 9,532,944, use patent
patent.txt line 15,416
Flags
use code U-1900
Product numbers
001
19 Oct 2035 · NDA 213978 · VARENICLINE TARTRATE
US 9,597,284, use patent
patent.txt line 15,417
Flags
use code U-1900
Product numbers
001
20 Oct 2035 · NDA 202860 · NITRIC OXIDE
US 10,737,051, product patent
patent.txt line 3,409
Flags
product
Product numbers
001
21 Oct 2035 · NDA 212028 · LEMBOREXANT
US 10,188,652, product and use patent
patent.txt lines 13,436, 13,440
Flags
product use code U-2791
Product numbers
001, 002
21 Oct 2035 · NDA 212028 · LEMBOREXANT
US 10,702,529, product patent
patent.txt lines 13,437, 13,441
Flags
product
Product numbers
001, 002
21 Oct 2035 · NDA 212028 · LEMBOREXANT
US 11,026,944, product patent
patent.txt lines 13,438, 13,442
Flags
product
Product numbers
001, 002
21 Oct 2035 · NDA 216962 · FOSCARBIDOPA; FOSLEVODOPA
US 10,174,061, product and use patent
patent.txt line 19,083
Flags
product use code U-4030
Product numbers
001
21 Oct 2035 · NDA 216962 · FOSCARBIDOPA; FOSLEVODOPA
US 10,730,895, substance patent
patent.txt line 19,084
Flags
substance
Product numbers
001
21 Oct 2035 · NDA 216962 · FOSCARBIDOPA; FOSLEVODOPA
US 9,446,059, substance and product and use patent
patent.txt line 19,086
Flags
substance product use code U-4030
Product numbers
001
23 Oct 2035 · NDA 212320 · FERRIC MALTOL
US 9,802,973, substance and product and use patent
patent.txt line 13,948
Flags
substance product use code U-2603
Product numbers
001
25 Oct 2035 · NDA 212479 · METHOTREXATE
US 12,605,385, product patent
patent.txt line 14,052
Flags
product
Product numbers
001
28 Oct 2035 · NDA 209472 · PEMETREXED
US 9,604,990, substance patent
patent.txt line 10,394
Flags
substance
Product numbers
001
28 Oct 2035 · NDA 212479 · METHOTREXATE
US 11,129,833, product patent
patent.txt line 14,046
Flags
product
Product numbers
001
29 Oct 2035 · NDA 214787 · REMDESIVIR
US 9,724,360, substance and product patent
patent.txt lines 16,155, 16,187
Flags
substance product
Product numbers
001, 002
29 Oct 2035 · NDA 214787 · REMDESIVIR
US 9,949,994, substance patent
patent.txt lines 16,157, 16,189
Flags
substance
Product numbers
001, 002
29 Oct 2035 · NDA 215358 · ASCIMINIB HYDROCHLORIDE
US 8,829,195, substance and use patent
patent.txt lines 16,809, 16,813, 16,817
Flags
substance use code U-1374
Product numbers
001, 002, 003
29 Oct 2035 · NDA 215842 · NEDOSIRAN SODIUM
US 11,053,502, substance and product patent
patent.txt lines 17,555, 17,561, 17,567
Flags
substance product
Product numbers
001, 002, 003
30 Oct 2035 · NDA 212038 · METHYLPHENIDATE HYDROCHLORIDE
US 10,111,839, use patent
patent.txt lines 13,444, 13,456, 13,468, 13,480, 13,492, 13,504
Flags
use code U-2357
Product numbers
001, 002, 003, 004, 005, 006
30 Oct 2035 · NDA 212038 · METHYLPHENIDATE HYDROCHLORIDE
US 10,292,938, product patent
patent.txt lines 13,445, 13,457, 13,469, 13,481, 13,493, 13,505
Flags
product
Product numbers
001, 002, 003, 004, 005, 006
30 Oct 2035 · NDA 212038 · METHYLPHENIDATE HYDROCHLORIDE
US 10,292,939, product and use patent
patent.txt lines 13,446, 13,458, 13,470, 13,482, 13,494, 13,506
Flags
product use code U-2357
Product numbers
001, 002, 003, 004, 005, 006
30 Oct 2035 · NDA 212038 · METHYLPHENIDATE HYDROCHLORIDE
US 10,449,159, use patent
patent.txt lines 13,447, 13,459, 13,471, 13,483, 13,495, 13,507
Flags
use code U-2357
Product numbers
001, 002, 003, 004, 005, 006
30 Oct 2035 · NDA 212038 · METHYLPHENIDATE HYDROCHLORIDE
US 10,500,162, use patent
patent.txt lines 13,448, 13,460, 13,472, 13,484, 13,496, 13,508
Flags
use code U-2357
Product numbers
001, 002, 003, 004, 005, 006
30 Oct 2035 · NDA 212038 · METHYLPHENIDATE HYDROCHLORIDE
US 10,507,186, product patent
patent.txt lines 13,449, 13,461, 13,473, 13,485, 13,497, 13,509
Flags
product
Product numbers
001, 002, 003, 004, 005, 006
30 Oct 2035 · NDA 212038 · METHYLPHENIDATE HYDROCHLORIDE
US 10,512,612, product patent
patent.txt lines 13,450, 13,462, 13,474, 13,486, 13,498, 13,510
Flags
product
Product numbers
001, 002, 003, 004, 005, 006
30 Oct 2035 · NDA 212038 · METHYLPHENIDATE HYDROCHLORIDE
US 10,512,613, use patent
patent.txt lines 13,451, 13,463, 13,475, 13,487, 13,499, 13,511
Flags
use code U-2357
Product numbers
001, 002, 003, 004, 005, 006
30 Oct 2035 · NDA 212038 · METHYLPHENIDATE HYDROCHLORIDE
US 10,568,841, product and use patent
patent.txt lines 13,452, 13,464, 13,476, 13,488, 13,500, 13,512
Flags
product use code U-2357
Product numbers
001, 002, 003, 004, 005, 006
30 Oct 2035 · NDA 212038 · METHYLPHENIDATE HYDROCHLORIDE
US 10,688,060, product patent
patent.txt lines 13,453, 13,465, 13,477, 13,489, 13,501, 13,513
Flags
product
Product numbers
001, 002, 003, 004, 005, 006
30 Oct 2035 · NDA 212038 · METHYLPHENIDATE HYDROCHLORIDE
US 9,974,752, product patent
patent.txt lines 13,455, 13,467, 13,479, 13,491, 13,503, 13,515
Flags
product
Product numbers
001, 002, 003, 004, 005, 006
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,039,800, use patent
patent.txt line 8,581
Flags
use code U-1723
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,039,800, use patent
patent.txt line 8,582
Flags
use code U-185
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,039,800, use patent
patent.txt line 8,583
Flags
use code U-1864
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,039,800, use patent
patent.txt line 8,584
Flags
use code U-1991
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,039,800, use patent
patent.txt line 8,585
Flags
use code U-3
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,039,800, use patent
patent.txt line 8,586
Flags
use code U-71
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,039,800, use patent
patent.txt line 8,587
Flags
use code U-8
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,265,370, product patent
patent.txt line 8,588
Flags
product
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,406,199, use patent
patent.txt line 8,589
Flags
use code U-1723
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,406,199, use patent
patent.txt line 8,590
Flags
use code U-185
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,406,199, use patent
patent.txt line 8,591
Flags
use code U-1864
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,406,199, use patent
patent.txt line 8,592
Flags
use code U-1991
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,406,199, use patent
patent.txt line 8,593
Flags
use code U-3
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,406,199, use patent
patent.txt line 8,594
Flags
use code U-71
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,406,199, use patent
patent.txt line 8,595
Flags
use code U-8
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 10,940,177, product patent
patent.txt line 8,596
Flags
product
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 11,179,434, product patent
patent.txt line 8,597
Flags
product
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 11,771,733, product patent
patent.txt line 8,598
Flags
product
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 12,128,083, product patent
patent.txt line 8,599
Flags
product
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 12,186,360, product patent
patent.txt line 8,600
Flags
product
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 12,433,931, use patent
patent.txt line 8,601
Flags
use code U-1723
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 12,433,931, use patent
patent.txt line 8,602
Flags
use code U-1864
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 12,433,931, use patent
patent.txt line 8,603
Flags
use code U-3
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 9,463,183, product patent
patent.txt line 8,604
Flags
product
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 9,616,096, use patent
patent.txt line 8,605
Flags
use code U-1723
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 9,616,096, use patent
patent.txt line 8,606
Flags
use code U-185
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 9,616,096, use patent
patent.txt line 8,607
Flags
use code U-1864
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 9,616,096, use patent
patent.txt line 8,608
Flags
use code U-1991
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 9,616,096, use patent
patent.txt line 8,609
Flags
use code U-3
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 9,616,096, use patent
patent.txt line 8,610
Flags
use code U-71
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 9,616,096, use patent
patent.txt line 8,611
Flags
use code U-8
Product numbers
001
6 Nov 2035 · NDA 208401 · LISINOPRIL
US 9,814,751, product patent
patent.txt line 8,612
Flags
product
Product numbers
001
6 Nov 2035 · NDA 209819 · BUPRENORPHINE
US 11,000,520, use patent
patent.txt lines 10,840, 10,865
Flags
use code U-3111
Product numbers
001, 002
6 Nov 2035 · NDA 209819 · BUPRENORPHINE
US 11,839,611, use patent
patent.txt lines 10,841, 10,866
Flags
use code U-3111
Product numbers
001, 002
6 Nov 2035 · NDA 209819 · BUPRENORPHINE
US 12,622,904, use patent
patent.txt lines 10,842, 10,867
Flags
use code U-4528
Product numbers
001, 002
6 Nov 2035 · NDA 211962 · VANCOMYCIN HYDROCHLORIDE
US 10,039,804, product and use patent
patent.txt lines 13,250, 13,256, 13,262, 13,268, 13,274, 13,280, 13,286
Flags
product use code U-282
Product numbers
001, 002, 003, 004, 005, 006, 007
6 Nov 2035 · NDA 211962 · VANCOMYCIN HYDROCHLORIDE
US 10,188,697, product and use patent
patent.txt lines 13,251, 13,257, 13,263, 13,269, 13,275, 13,281, 13,287
Flags
product use code U-282
Product numbers
001, 002, 003, 004, 005, 006, 007
6 Nov 2035 · NDA 211962 · VANCOMYCIN HYDROCHLORIDE
US 10,849,956, product patent
patent.txt lines 13,252, 13,258, 13,264, 13,270, 13,276, 13,282, 13,288
Flags
product
Product numbers
001, 002, 003, 004, 005, 006, 007
6 Nov 2035 · NDA 211962 · VANCOMYCIN HYDROCHLORIDE
US 11,517,609, use patent
patent.txt lines 13,253, 13,259, 13,265, 13,271, 13,277, 13,283, 13,289
Flags
use code U-282
Product numbers
001, 002, 003, 004, 005, 006, 007
6 Nov 2035 · NDA 211962 · VANCOMYCIN HYDROCHLORIDE
US 11,628,200, product patent
patent.txt lines 13,254, 13,260, 13,266, 13,272, 13,278, 13,284, 13,290
Flags
product
Product numbers
001, 002, 003, 004, 005, 006, 007
6 Nov 2035 · NDA 211962 · VANCOMYCIN HYDROCHLORIDE
US 12,161,690, product patent
patent.txt lines 13,255, 13,261, 13,267, 13,273, 13,279, 13,285, 13,291
Flags
product
Product numbers
001, 002, 003, 004, 005, 006, 007
6 Nov 2035 · NDA 213895 · VANCOMYCIN
US 10,039,804, product and use patent
patent.txt line 15,298
Flags
product use code U-282
Product numbers
001
6 Nov 2035 · NDA 213895 · VANCOMYCIN
US 10,188,697, product and use patent
patent.txt line 15,299
Flags
product use code U-282
Product numbers
001
6 Nov 2035 · NDA 213895 · VANCOMYCIN
US 10,849,956, product patent
patent.txt line 15,300
Flags
product
Product numbers
001
6 Nov 2035 · NDA 213895 · VANCOMYCIN
US 11,000,567, product patent
patent.txt line 15,301
Flags
product
Product numbers
001
6 Nov 2035 · NDA 213895 · VANCOMYCIN
US 11,517,609, use patent
patent.txt line 15,302
Flags
use code U-282
Product numbers
001
10 Nov 2035 · NDA 208772 · BRIGATINIB
US 10,385,078, substance and product and use patent
patent.txt lines 9,315, 9,319, 9,323
Flags
substance product use code U-2837
Product numbers
001, 002, 003
12 Nov 2035 · NDA 215833 · LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
US 11,951,190, use patent
patent.txt line 17,545
Flags
use code U-4169
Product numbers
001
12 Nov 2035 · NDA 215833 · LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
US 11,951,190, use patent
patent.txt line 17,546
Flags
use code U-4593
Product numbers
001
12 Nov 2035 · NDA 215833 · LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
US 11,951,190, use patent
patent.txt line 17,547
Flags
use code U-4594
Product numbers
001
12 Nov 2035 · NDA 216665 · DIAZOXIDE CHOLINE
US 12,178,823, use patent
patent.txt lines 18,895, 18,901, 18,907
Flags
use code U-4167
Product numbers
001, 002, 003
12 Nov 2035 · NDA 216665 · DIAZOXIDE CHOLINE
US 12,343,348, use patent
patent.txt lines 18,896, 18,902, 18,908
Flags
use code U-4211
Product numbers
001, 002, 003
12 Nov 2035 · NDA 216665 · DIAZOXIDE CHOLINE
US 12,419,895, use patent
patent.txt lines 18,897, 18,903, 18,909
Flags
use code U-4275
Product numbers
001, 002, 003
12 Nov 2035 · NDA 216665 · DIAZOXIDE CHOLINE
US 9,757,384, use patent
patent.txt lines 18,900, 18,906, 18,912
Flags
use code U-4167
Product numbers
001, 002, 003
13 Nov 2035 · NDA 205474 · GUAIFENESIN; HYDROCODONE BITARTRATE
US 10,105,324, substance and product and use patent
patent.txt line 5,433
Flags
substance product use code U-2023
Product numbers
001
13 Nov 2035 · NDA 205474 · GUAIFENESIN; HYDROCODONE BITARTRATE
US 9,549,907, substance and product and use patent
patent.txt line 5,434
Flags
substance product use code U-2023
Product numbers
001
13 Nov 2035 · NDA 205474 · GUAIFENESIN; HYDROCODONE BITARTRATE
US 9,808,431, substance and product and use patent
patent.txt line 5,435
Flags
substance product use code U-2023
Product numbers
001
16 Nov 2035 · NDA 204063 · DIMETHYL FUMARATE
US 10,959,972, use patent
patent.txt lines 4,255, 4,264
Flags
use code U-1384
Product numbers
001, 002
16 Nov 2035 · NDA 204063 · DIMETHYL FUMARATE
US 11,007,166, use patent
patent.txt lines 4,257, 4,266
Flags
use code U-1384
Product numbers
001, 002
16 Nov 2035 · NDA 204063 · DIMETHYL FUMARATE
US 11,007,167, use patent
patent.txt lines 4,258, 4,267
Flags
use code U-1384
Product numbers
001, 002
16 Nov 2035 · NDA 204063 · DIMETHYL FUMARATE
US 11,129,806, use patent
patent.txt lines 4,259, 4,268
Flags
use code U-1384
Product numbers
001, 002
16 Nov 2035 · NDA 204063 · DIMETHYL FUMARATE
US 11,246,850, use patent
patent.txt lines 4,260, 4,269
Flags
use code U-1384
Product numbers
001, 002
16 Nov 2035 · NDA 210861 · LAROTRECTINIB SULFATE
US 10,172,861, substance and product patent
patent.txt lines 12,221, 12,236
Flags
substance product
Product numbers
001, 002
16 Nov 2035 · NDA 210861 · LAROTRECTINIB SULFATE
US 10,285,993, use patent
patent.txt lines 12,222, 12,237
Flags
use code U-2470
Product numbers
001, 002
16 Nov 2035 · NDA 210861 · LAROTRECTINIB SULFATE
US 10,813,936, use patent
patent.txt lines 12,225, 12,240
Flags
use code U-2987
Product numbers
001, 002
16 Nov 2035 · NDA 210861 · LAROTRECTINIB SULFATE
US 9,782,414, use patent
patent.txt lines 12,233, 12,248
Flags
use code U-2475
Product numbers
001, 002
16 Nov 2035 · NDA 211710 · LAROTRECTINIB SULFATE
US 10,172,861, substance patent
patent.txt line 13,073
Flags
substance
Product numbers
001
16 Nov 2035 · NDA 211710 · LAROTRECTINIB SULFATE
US 9,782,414, use patent
patent.txt line 13,086
Flags
use code U-2471
Product numbers
001
17 Nov 2035 · NDA 216974 · DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
US 10,376,499, product and use patent
patent.txt line 19,089
Flags
product use code U-2840
Product numbers
001
17 Nov 2035 · NDA 216974 · DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
US 9,968,593, product and use patent
patent.txt line 19,092
Flags
product use code U-2840
Product numbers
001
19 Nov 2035 · NDA 209863 · TESTOSTERONE ENANTHATE
US 9,744,302, product patent
patent.txt lines 10,937, 10,960, 10,983
Flags
product
Product numbers
001, 002, 003
26 Nov 2035 · NDA 219301 · SEBETRALSTAT
US 10,364,238, substance and product patent
patent.txt line 21,586
Flags
substance product
Product numbers
001
26 Nov 2035 · NDA 219301 · SEBETRALSTAT
US 10,611,758, use patent
patent.txt line 21,587
Flags
use code U-4223
Product numbers
001
26 Nov 2035 · NDA 219301 · SEBETRALSTAT
US 11,001,578, substance and product patent
patent.txt line 21,588
Flags
substance product
Product numbers
001
26 Nov 2035 · NDA 219301 · SEBETRALSTAT
US 11,084,809, substance and product and use patent
patent.txt line 21,589
Flags
substance product use code U-4223
Product numbers
001
26 Nov 2035 · NDA 219301 · SEBETRALSTAT
US 11,198,691, use patent
patent.txt line 21,590
Flags
use code U-4223
Product numbers
001
29 Nov 2035 · NDA 214907 · PAFOLACIANINE SODIUM
US 9,061,057, substance and product and use patent
patent.txt line 16,320
Flags
substance product use code U-3291
Product numbers
001
1 Dec 2035 · NDA 210852 · CYCLOPHOSPHAMIDE
US 11,382,923, product patent
patent.txt lines 12,177, 12,179, 12,181
Flags
product
Product numbers
001, 002, 003
2 Dec 2035 · NDA 210607 · TAFENOQUINE SUCCINATE
US 10,342,791, use patent
patent.txt line 12,047
Flags
use code U-2582
Product numbers
001
2 Dec 2035 · NDA 210607 · TAFENOQUINE SUCCINATE
US 10,888,558, use patent
patent.txt line 12,048
Flags
use code U-2582
Product numbers
001
2 Dec 2035 · NDA 210607 · TAFENOQUINE SUCCINATE
US 11,744,828, use patent
patent.txt line 12,049
Flags
use code U-2582
Product numbers
001
2 Dec 2035 · NDA 210607 · TAFENOQUINE SUCCINATE
US 12,616,689, use patent
patent.txt line 12,050
Flags
use code U-2582
Product numbers
001
3 Dec 2035 · NDA 210951 · APALUTAMIDE
US 12,303,493, product patent
patent.txt lines 12,437, 12,455
Flags
product
Product numbers
001, 002
4 Dec 2035 · NDA 218784 · VORASIDENIB
US 11,844,758, use patent
patent.txt lines 21,300, 21,305
Flags
use code U-3977
Product numbers
001, 002
10 Dec 2035 · NDA 213498 · PONESIMOD
US 10,220,023, use patent
patent.txt lines 15,068, 15,074
Flags
use code U-3103
Product numbers
001, 010
10 Dec 2035 · NDA 213498 · PONESIMOD
US 12,336,980, use patent
patent.txt lines 15,070, 15,076
Flags
use code U-3103
Product numbers
001, 010
14 Dec 2035 · NDA 208798 · FLUTICASONE PROPIONATE
US 10,918,816, product patent
patent.txt lines 9,478, 9,488, 9,498, 9,512
Flags
product
Product numbers
004, 005, 006, 008
14 Dec 2035 · NDA 208799 · FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE
US 10,918,816, product patent
patent.txt lines 9,542, 9,556, 9,568
Flags
product
Product numbers
004, 005, 006
19 Dec 2035 · NDA 211723 · TAZEMETOSTAT HYDROBROMIDE
US 10,786,511, product patent
patent.txt line 13,097
Flags
product
Product numbers
001
28 Dec 2035 · NDA 021064 · PERFLUTREN
US 10,022,460, substance and product patent
patent.txt line 454
Flags
substance product
Product numbers
002
28 Dec 2035 · NDA 021064 · PERFLUTREN
US 10,583,207, use patent
patent.txt lines 445, 455
Flags
use code U-665
Product numbers
001, 002
28 Dec 2035 · NDA 021064 · PERFLUTREN
US 11,395,856, substance and product and use patent
patent.txt line 459
Flags
substance product use code U-665
Product numbers
002
29 Dec 2035 · NDA 214375 · XENON XE-129 HYPERPOLARIZED
US 11,052,161, product patent
patent.txt line 15,735
Flags
product
Product numbers
001
30 Dec 2035 · NDA 208054 · FLUCICLOVINE F-18
US 10,124,079, use patent
patent.txt line 8,035
Flags
use code U-2450
Product numbers
001
30 Dec 2035 · NDA 208054 · FLUCICLOVINE F-18
US 10,716,868, use patent
patent.txt line 8,036
Flags
use code U-2450
Product numbers
001
30 Dec 2035 · NDA 208054 · FLUCICLOVINE F-18
US 10,933,147, use patent
patent.txt line 8,037
Flags
use code U-2450
Product numbers
001
30 Dec 2035 · NDA 208054 · FLUCICLOVINE F-18
US 10,967,077, use patent
patent.txt line 8,039
Flags
use code U-2450
Product numbers
001

Pediatric exclusivity, as listed (19)

3 Aug 2035 · NDA 202324 · AXITINIB
US 10,570,202 with pediatric exclusivity, as listed
patent.txt lines 3,047, 3,056
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
3 Aug 2035 · NDA 202324 · AXITINIB
US 12,534,530 with pediatric exclusivity, as listed
patent.txt lines 3,051, 3,060
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
19 Aug 2035 · NDA 020845 · NITRIC OXIDE
US 9,279,794 with pediatric exclusivity, as listed
patent.txt line 240
Flags
product pediatric, as listed by FDA (from the base row)
Product numbers
003
9 Sep 2035 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE
US 10,329,260 with pediatric exclusivity, as listed
patent.txt lines 15,465, 15,497
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
9 Sep 2035 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE
US 10,689,346 with pediatric exclusivity, as listed
patent.txt lines 15,469, 15,501
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
9 Sep 2035 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE
US 11,230,530 with pediatric exclusivity, as listed
patent.txt lines 15,473, 15,505
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
9 Sep 2035 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE
US 11,708,333 with pediatric exclusivity, as listed
patent.txt lines 15,477, 15,509
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
9 Sep 2035 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE
US 12,116,346 with pediatric exclusivity, as listed
patent.txt lines 15,479, 15,511
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
9 Sep 2035 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE
US 10,329,260 with pediatric exclusivity, as listed
patent.txt lines 21,882, 21,914, 21,946, 21,978
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
9 Sep 2035 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE
US 10,689,346 with pediatric exclusivity, as listed
patent.txt lines 21,886, 21,918, 21,950, 21,982
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
9 Sep 2035 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE
US 11,230,530 with pediatric exclusivity, as listed
patent.txt lines 21,890, 21,922, 21,954, 21,986
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
9 Sep 2035 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE
US 11,708,333 with pediatric exclusivity, as listed
patent.txt lines 21,894, 21,926, 21,958, 21,990
Flags
pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
9 Sep 2035 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE
US 12,116,346 with pediatric exclusivity, as listed
patent.txt lines 21,896, 21,928, 21,960, 21,992
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
7 Oct 2035 · NDA 214094 · BEROTRALSTAT DIHYDROCHLORIDE
US 10,125,102 with pediatric exclusivity, as listed
patent.txt lines 15,463, 15,495
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002
7 Oct 2035 · NDA 219776 · BEROTRALSTAT DIHYDROCHLORIDE
US 10,125,102 with pediatric exclusivity, as listed
patent.txt lines 21,880, 21,912, 21,944, 21,976
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001, 002, 003, 004
8 Nov 2035 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US RE48923 with pediatric exclusivity, as listed
patent.txt line 10,322
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001
8 Nov 2035 · NDA 215110 · GLECAPREVIR; PIBRENTASVIR
US RE48923 with pediatric exclusivity, as listed
patent.txt line 16,495
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001
5 Dec 2035 · NDA 209394 · GLECAPREVIR; PIBRENTASVIR
US 9,321,807 with pediatric exclusivity, as listed
patent.txt line 10,316
Flags
substance pediatric, as listed by FDA (from the base row)
Product numbers
001
5 Dec 2035 · NDA 215110 · GLECAPREVIR; PIBRENTASVIR
US 9,321,807 with pediatric exclusivity, as listed
patent.txt line 16,490
Flags
substance product pediatric, as listed by FDA (from the base row)
Product numbers
001

Non-patent exclusivity (1)

12 Dec 2035 · NDA 219491 · ZOLIFLODACIN
GAIN exclusivity
exclusivity.txt line 2,299
Definition
Generating Antibiotic Incentives Now (to be checked against FDA's list)
Product numbers
001